Reactivity of human lymphoid cells following neuraminidase treatment
Flye, M.W.; Grothaus, E.A.; Amos, D.B.
Surgical Forum 22: 97-99
1971
ISSN/ISBN: 0071-8041 PMID: 5121479 Document Number: 34908
Document emailed within 1 workday
Related Documents
Ray, P.K.; Gewurz, H.; Simmons, R.L. 1972: The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity Clinical and Experimental Immunology 11(3): 441-460Pauly, J.L.; Germain, M.J.; Han, T. 1978: Neuraminidase alteration of human lymphocyte reactivity to mitogens, antigens and allogenic lymphocytes Journal of Medicine 9(3): 223-236
Sorg, C.; Geczy, C.L. 1978: Antibodies to guinea pig lymphokines. VII. Reactivity with products of lymphoid and nonlymphoid cells Journal of Immunology 121(3): 1199-1205
Rotter, V.; Trainin, N. 1975: Increased mitogenic reactivity of lymphoid cells to T lectins induced by thymus humoral factor Israel Journal of Medical Sciences 11(12): 1381-1382
Ray, R.K.; Simmons, R.L. 1973: Differential release of sialic acid from normal and malignant cells by Vibrio cholerae neuraminidase or influenza virus neuraminidase Cancer Research 33(5): 936-939
Luther, P.; Klamm, H.; Weber, S. 1983: Simple detection of mumps virus neuraminidase and anti-neuraminidase with the lectin neuraminidase test Acta Virologica 27(1): 89-91
Ogasawara, M.; Takebe, T.; Ishii, K. 1988: Tumor-associated antigen defined by a monoclonal antibody against neuraminidase-treated human cancer cells Cancer Research 48(2): 412-417
Abken, H.; Bützler, C.; Willecke, K. 1987: Adenovirus type 5 persisting in human lymphocytes is unlikely to be involved in immortalization of lymphoid cells by fusion with cytoplasts or by transfection with DNA of mouse L cells Anticancer Research 7(4a): 553-558
Moore, G.E. 1973: Methodology for cultured human lymphoid cells Birth Defects Original Article Series 9(1): 31-39
Prema, S.; Madyastha, K.R.; Sahasrabudhe, M.B. 1978: Immunological cross-reactivity of anti-sera raised with fluoro dinitro benzene tagged normal human leukocytes against human leukaemic cells Indian Journal of Cancer 15(1): 53-57
Karolak, L.; Tod, M.; Leon, A.; Heudes, A.M.; Petitjean, O.; Laroche, L. 1992: In vitro kinetics of 8-methoxypsoralen penetration into human lymphoid cells Photodermatology Photoimmunology and Photomedicine 9(2): 58-60
Barlogie, B.; Drewinko, B.; Benjamin, R.S.; Freireich, E.J. 1976: Kinetic response of human lymphoid cells to adriamycin-DNA complex in vitro Cancer Research 36(7 Part 1): 2540-2544
Weiss, L.; Sinks, L.F. 1970: The elekctrokinetic surfaces of human cells of lymphoid origin and their ribonuclease susceptibility Cancer Research 30(1): 90-94
Doherty, T.A.; Broide, D.H. 2015: Group 2 innate lymphoid cells: new players in human allergic diseases Journal of Investigational Allergology and Clinical Immunology 25(1): 1-11; Quiz 2p Following 11
Kamiński, M.J.; Bem, W.; Majewski, S.; Kamińska, G.; Szmurło, A. 1981: Angiogenesis induction by xenogeneic lymphoid and non-lymphoid cells in mice Archivum Immunologiae et Therapiae Experimentalis 29(4): 521-523
Fil'chenkov, A.A.; Zavelevich, M.P.; Khranovskaia, N.N.; Mykhaĭlenko, V.M. 2006: Apoptosis of human malignant lymphoid NAMALWA cells induced by resveratrol and quercetin Ukrains'kyi Biokhimichnyi Zhurnal 78(4): 112-119
Hütteroth, T.H.; Cleve, H.; Litwin, S.D. 1973: Modulation of membrane associated immunoglobulins of cultured human lymphoid cells by specific antibody Journal of Immunology 110(5): 1325-1333
Beyer, C.F.; Bowers, W.E. 1978: Lymphocyte transformation induced by chemical modification of membrane components. II. Effect of neuraminidase treatment of responder cells on proliferation and cytotoxicity in indirect stimulation Journal of Immunology 121(5): 1790-1798
Earle, M.F.; Glazer, R.I. 1983: Activity and metabolism of 2-beta-D-ribofuranosylthiazole-4-carboxamide in human lymphoid tumor cells in culture Cancer Research 43(1): 133-137
Barroso, L.; Treanor, J.; Gubareva, L.; Hayden, F.G. 2005: Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment Antiviral Therapy 10(8): 901-910